Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase III studies - Bruix, J; Cheng, A L; Meinhardt, G; Nakajima, K; De Sanctis, Y; Llovet, J (J Hepatol, 2017)